Cytochalasin E

Cytochalasin E[1]
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.048.018
EC Number 252-835-7
Properties
C28H33NO7
Molar mass 495.57 g·mol−1
Density 1.309 g/ml
Hazards
Main hazards Toxic
T+
R-phrases (outdated) R26/27/28 R63
S-phrases (outdated) S28 S36/37 S45
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references

Cytochalasin E, a member of the cytochalasin group, is an inhibitor of actin polymerization in blood platelets. It inhibits angiogenesis and tumor growth. Unlike cytochalasin A and cytochalasin B, it does not inhibit glucose transport.

Because of its antiangiogenic effect, cytochalasin E is a potential drug for age-related macular degeneration, a kind of blindness caused by an abnormal proliferation of blood vessels in the eye.[2]

Cytochalasin E was found to be a potent and selective inhibitor of bovine capillary endothelial (BCE) cell proliferation. Cytochalasin E differs from other cytochalasin molecules by having an epoxide, which is required for specificity and potency. Cytochalasin E is a potent antiangiogenic agent that may be useful for treatments of cancer and other pathologic angiogenesis.[3]

References

  1. Cytochalasin E from Aspergillus clavatus at Sigma-Aldrich
  2. eyesight.org Archived 2006-05-19 at the Wayback Machine.
  3. Udagawa, T; Yuan, J; Panigrahy, D; Chang, YH; Shah, J; D'Amato, RJ (August 2000). "Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth". J. Pharmacol. Exp. Ther. 294: 421–7. PMID 10900214.

External pages

Cytochalasin E from Fermentek
Cytochalasin E from Cayman Chemical


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.